Showing results (151-160 of 1,034) with videos related to

Sort By:
Pageof 104
Expert Opinion on Drug Safety|November 6, 2025
Long-term safety of oral antiplatelet strategies for patients with acute coronary syndrome undergoing percutaneous coronary interventionClaudio Laudani, Luis Ortega-Paz, Davide Capodanno, et al.
The American Journal of Cardiology|July 9, 2014
Meta-analysis of randomized controlled trials of preprocedural statin administration for reducing contrast-induced acute kidney injury in patients undergoing coronary catheterizationDaniele Giacoppo, Davide Capodanno, Piera Capranzano, et al.
Journal of the American Heart Association|November 24, 2020
Coronavirus Disease 2019-Associated Thrombosis and Coagulopathy: Review of the Pathophysiological Characteristics and Implications for Antithrombotic ManagementLuis Ortega-Paz, Davide Capodanno, Gilles Montalescot, et al.
Revista Espanola De Cardiologia (English Ed.)|October 17, 2023
Association of trial characteristics with simultaneous publication and its impact on citations and mentions: a cross-sectional studyMarco Spagnolo, Antonio Greco, Claudio Laudani, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 2, 2024
Percutaneous interventions for pulmonary embolismSimone Finocchiaro, Maria Sara Mauro, Carla Rochira, et al.
JACC. Cardiovascular Interventions|October 11, 2023
Complete Percutaneous Coronary Revascularization in Acute Coronary Syndromes With Multivessel Coronary Disease: A Systematic ReviewDenise Cristiana Faro, Claudio Laudani, Federica Giuseppa Agnello, et al.
JACC. Cardiovascular Interventions|February 11, 2022
Short Duration of DAPT Versus De-Escalation After Percutaneous Coronary Intervention for Acute Coronary SyndromesClaudio Laudani, Antonio Greco, Giovanni Occhipinti, et al.
Recent Patents on Cardiovascular Drug Discovery|August 13, 2011
Clinical pharmacotherapy and drug development for pulmonary arterial hypertensionMassimiliano Mulè, Marilena Scarabelli, Davide Capodanno, et al.
Expert Opinion on Investigational Drugs|May 13, 2020
Selatogrel, a novel P2Y12 inhibitor: a review of the pharmacology and clinical developmentRocco P Milluzzo, Gabriele A Franchina, Davide Capodanno, et al.
European Heart Journal. Case Reports|October 6, 2025
Successful mitral-transcatheter edge to edge repair in a young patient with severe primary mitral regurgitation unsuitable for surgery: a case reportGiovanni Bellina, Salvatore Scandura, Carmelo Grasso, et al.
Pageof 104